• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

AdDIT

ADOLESCENT TYPE 1 DIABETES CARDIO-RENAL INTERVENTION TRIAL

  • Home
  • Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)
  • How we did it
  • AdDIT Cardiovascular Assessments
  • AdDIT Results
  • AdDIT Funders
  • Contact AdDIT UK
  • Co-ordinating Centres
  • AdDIT Follow Up
  • AdDIT Follow Up active sites
  • AdDIT Publications
  • Background to AdDIT
You are here: Home / Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT) / AdDIT Funders

AdDIT Funders

JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested more than $2 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our six international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D.

Link to site 

Twitter: @JDRF

Diabetes UK is a co-funder of AdDIT and the leading charitable funder of diabetes research in the UK. They invest around £7 million every year to bring about life-changing breakthroughs in care, treatment and prevention, ultimately bringing us closer to a cure.

Link to site 

 

The British Heart Foundation are the largest independent funder of cardiovascular research in the UK, turning your donations into discoveries. With your help, we invest £100m a year to find the next breakthrough against heart and circulatory diseases.

Link to Site

 

Additional support Provided by:

Pfizer, UK

UK Medical Director – Dr Berkeley Philips

Provided the investigational medicinal products, Atorvastatin, Quinapril and matched Placebos.


AARDEX Ltd, Switzerland; Provided Electronic Pill Monitoring Caps.

Now trading as WestRock Switzerland Ltd

Canada received additional funding from:

Link to site

Thank you to Catalent Pharma Solutions UK who helped us package and distribute all of the drugs through the trial. 

Link to site

 

 

Primary Sidebar

Contact Us

Social

A Twitter List by AdDIT2017

Footer

Co-ordinating Centres

Cookie and Privacy Policy

Site Map

  • Home
  • Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)
  • How we did it
  • AdDIT Cardiovascular Assessments
  • AdDIT Results
  • AdDIT Funders
  • Contact AdDIT UK
  • Co-ordinating Centres
  • AdDIT Follow Up
  • AdDIT Follow Up active sites
  • AdDIT Publications
  • Background to AdDIT

Copyright © 2022  AdDIT Trial · Contact Form . Hosted by CSCS

Copyright © 2022 · Milan Pro on Genesis Framework · WordPress · Log in

  • Twitter